4 Hot Penny Stocks Making Waves : ALKM, FBCD, RMHI, RLFTF

Penny stocks are high-risk investment plays with the potential of above-average returns with the slightest of price movements. Therefore, investing in them requires lots of insight and caution to circumvent the inherent risks. Nevertheless, their discounted valuations make them ideal plays for any investors who know exactly what they are doing.

Stock quality picking is the only way to make a fortune while investing in penny stocks. Through fundamental analysis focusing on the technologies, the companies are offering or the products and services on offer, it becomes much easier to discover gems likely to explode and generate significant value in the long run. This article focuses on sub-penny stocks worth watching this month, Including AKLM, STGZ, FBCD, and RMHI.

Alkame Holdings Improving Financials

Alkame Holdings, Inc. (OTC: ALKM) is a diversified holding company offering exposure in the beverage industry. Its core business revolves around its proprietary water technology supplemented by unique properties in food and beverage manufacturing. It’s also expanded its footprint into the multi-billion CBD/hemp food and beverage industry in pursuit of growth opportunities.

The small-cap firm has been building a solid foundation focusing on the utilization of its proprietary water technology where applicable while also acquiring other businesses to strengthen its portfolio. The diversified nature of its holdings in emerging business sectors has been one of the catalysts behind solid results in the recent past.

AKLM delivered solid financial results for its fiscal 2022. Revenues in the year were up 19% year over year to $780,000. Revenues could have been much higher had the company not faced supply constraints in the distribution and sale of its brands in the first half of the year. It is projecting revenues of over $900,000 for the current year, signaling it is in a robust growth phase.

Net profit totaled $820,000, helped by a one-time gain of $1.43 million following the extinguishment of debt and other derivative liabilities. The water technology firm remains in a solid financial position, having wiped out over $1 million in liabilities representing a 17% year-over-year decline.

Last year the Small Business Administration forgave a loan of $101,444 that Alkame Holdings had taken at the height of the pandemic through its Subsidiary Bell Food and Beverage. While the pandemic did affect AKLM operations, it has bounced back, depicted by the solid revenue growth. The health and wellness firm has been able to ride out the adverse financial impact of the pandemic, depicted by its solid financial position.

FBC Holding taps crypto opportunity with virtual wallet

FBC Holding, Inc. (OTC: FBCD) has transitioned from marketing and selling streetwear clothing, headwear, and accessories to pursuing growth opportunities around cryptocurrencies. Consequently, it has established a new subsidiary dubbed   Crypt Keeper App, expanding its footprint into the burgeoning digital economy.

Crypt Keeper App offers a secure and user-friendly cryptocurrency wallet that caters to the needs of people venturing into the world of digital assets. Its primary goal is to redefine how people handle and manage digital assets in pursuit of shareholder value. It is to offer a cryptocurrency wallet that will empower users to securely store, transfer and engage in a diverse range of digital assets.

FBC Holding has also set out to create a new industry standard by providing an all-in-one solution that caters to the needs of cryptocurrency enthusiasts. It also plans to drive innovation in the financial landscape by launching solutions that democratize access to cryptocurrencies while spearheading mainstream adoption.

Crypt Keeper is to differentiate itself from other virtual wallets in the market by offering an intuitive user interface perfect for seasoned and newcomers in the burgeoning crypto scene. It will also feature unmatched security prioritizing user security above anything, using ultramodern encryption protocols. The new virtual app also integrates leading blockchain networks to provide users with non-propelled access to a wide range of digital assets.

The virtual app will launch in the iOS App Store to offer a transformative virtual wallet experience worldwide and allow the FBC holdings to generate some value from transaction fees.

Retrieve Medical diagnosis software eliciting strong demand

Retrieve Medical, Inc. (OTC: RMHI) is a small-cap company offering exposure in the healthcare sector. Its core business revolves around delivering a proprietary software platform that allows physicians to diagnose various conditions accurately.

Retrieve’s Dx is the patented and proprietary language processor that makes it easier to understand a complex patient’s clinical history quickly. It analyzes physicians’ notes, lab results, radiology reports, and EKG interpretations. The software has proved to be highly effective in increasing physicians’ efficiency and improving patient outcomes.

Retrieve’s Dx ability to create additional revenues for healthcare providers has made it a hit in the healthcare industry. Retrieve Medical has already inked an agreement with a major enterprise technology company that serves over 40 hospitals in the US.

With the agreement, RMHI is on course to implement its patented software solution in various hospitals, which is expected to unlock new revenue avenues. By helping hospitals document patient diagnoses to produce better outcomes and improve quality scores, Retrieve Medical should generate some value on the side.

The addition of new customers utilizing the proprietary diagnosis software goes a long way in communicating the value proposition of the overall business. The new deal is expected to unlock new opportunities. Retrieve Medical remains optimistic about a strong commercial year.

Relief Therapeutics robust pipeline for unmet needs

Relief Therapeutics Holding (OTC:RLFTD) has carved a niche as a biopharmaceutical company focused on the development of novel treatments for metabolic, dermatological, and rare pulmonary diseases. Its primary goal is to offer rare disease patients therapies that significantly improve their condition and quality of life.

The commercial-stage biopharmaceutical company boasts a rich, diversified pipeline that addresses various unmet needs. PKU Go Like is its lead product being commercialized for the dietary management of phenylketonuria (“PKU”); the rare disorder affects over 350,000 people worldwide and is synonymous with neurophysiological dysfunction.

RLFTD has already inked a long-term distribution agreement with Vector Pharma FZCO (Vector Pharma) for the commercialization and distribution of PKU GOLIKE in the middle east. The agreement underscores the growing demand for optimized treatment in helping patients struggling with phenylketonuria (PKU). The agreement marks an important milestone in Relief Therapeutics’ global expansion strategy as it continues to pursue revenue opportunities.

RLFTF has also inked a collaboration and licensing agreement with Acer Therapeutics for the development and commercialization of ACER 001. The proprietary powder formulation is being tested to treat various unborn errors, including Urea Cycle Disorders and Maple Syrup Urine Disease.

Relief Therapeutics has already closed a private offering from which it raised CHF5 million in gross proceeds. It plans to use net proceeds from the offering to advance its pipeline and for general corporate purposes.